Netherton Syndrome is caused by mutations in SPINK5 encoding the serine protease inhibitor known as the lympho-epithelial Kazal-type-related inhibitor (LEKTI), and this has specific clinical parallels to AD patients. This evidence concerns the gene SPINK5 and Alzheimer disease.